|
시장보고서
상품코드
1991506
세포 신호전달 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Cell Signaling Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
세포 신호전달 시장 규모는 2025년 68억 4,000만 달러에서 2026년부터 2034년까지 CAGR 7.82%로 성장하여 2034년에는 134억 6,000만 달러에 달할 것으로 예상됩니다.
생의학 연구에서 세포가 어떻게 소통하고 생물학적 과정을 조절하는지를 탐구하는 노력이 계속되는 가운데, 세계 세포 신호전달 시장은 눈에 띄게 성장하고 있습니다. 세포 신호전달에는 세포의 증식, 면역반응, 질병 진행 등의 기능을 조절하는 복잡한 분자 경로가 관여합니다. 연구자들은 암, 신경질환, 자가면역질환 등의 질병을 이해하기 위해 이러한 경로를 연구하고 있습니다.
시장 성장은 생명과학 연구 및 신약개발에 대한 투자 확대에 의해 주도되고 있습니다. 제약회사와 생명공학 기업들은 잠재적인 약물 표적을 식별하고 새로운 치료법을 개발하기 위해 세포 신호전달 연구에 의존하고 있습니다. 이미징 시스템, 분자 분석 도구 등 실험 기술의 발전으로 신호전달 경로를 상세히 연구할 수 있는 능력이 향상되었습니다.
과학 연구를 통해 새로운 생물학적 메커니즘이 계속 밝혀지고 있기 때문에 세포 신호전달 시장의 향후 전망은 여전히 유망합니다. 유전체학 및 단백질학의 발전으로 세포 간 통신 네트워크에 대한 더 깊은 인사이트를 얻을 수 있습니다. 또한, 맞춤형 의료 및 표적치료에 대한 수요 증가도 시장 성장을 뒷받침할 것으로 예상됩니다. 생물 의학 연구가 발전함에 따라 세포 신호전달 기술은 복잡한 질병을 이해하는 데 중요한 역할을 할 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 세포 신호전달 시장 : 유형별
제5장 세계의 세포 신호전달 시장 : 제품별
제6장 세계의 세포 신호전달 시장 : 기술별
제7장 세계의 세포 신호전달 시장 : 경로별
제8장 세계의 세포 신호전달 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSM 26.04.14The Cell Signaling Market size is expected to reach USD 13.46 Billion in 2034 from USD 6.84 Billion (2025) growing at a CAGR of 7.82% during 2026-2034.
The global cell signaling market has expanded significantly as biomedical research continues to explore how cells communicate and regulate biological processes. Cell signaling involves complex molecular pathways that control functions such as cell growth, immune response, and disease progression. Researchers study these pathways to understand diseases such as cancer, neurological disorders, and autoimmune conditions.
Market growth is driven by increasing investments in life sciences research and drug discovery. Pharmaceutical and biotechnology companies rely on cell signaling studies to identify potential drug targets and develop new therapies. Advances in laboratory technologies, including imaging systems and molecular analysis tools, have improved the ability to study signaling pathways in detail.
The future outlook for the cell signaling market remains promising as scientific research continues to uncover new biological mechanisms. Advances in genomics and proteomics may provide deeper insights into cellular communication networks. Increasing demand for personalized medicine and targeted therapies is also expected to support market growth. As biomedical research progresses, cell signaling technologies will play an important role in understanding complex diseases.
MARKET SEGMENTATION
By Type
- Endocrine Signaling
- Paracrine Signaling
- Autocrine Signaling
- Others
By Product
- Consumables
- Instruments
By Technology
- Flow Cytometry
- Microscopy
- Western Blotting
- ELISA
- Others
By Pathway
- AKT Signaling Pathway
- AMPK Signaling Pathway
- ErbB/HER Signaling Pathway
- Other Signaling Pathway
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, QIAGEN NV, Becton, Dickinson and Company, BioRad Laboratories Inc, BioTechne Corporation, Cell Signaling Technology Inc, Danaher Corporation, Merck KGaA, PerkinElmer Inc, Promega Corporation
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL CELL SIGNALING MARKET: BY TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Type
- 4.2. Endocrine Signaling Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Paracrine Signaling Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Autocrine Signaling Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL CELL SIGNALING MARKET: BY PRODUCT 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Product
- 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL CELL SIGNALING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Technology
- 6.2. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Western Blotting Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL CELL SIGNALING MARKET: BY PATHWAY 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast Pathway
- 7.2. AKT Signaling Pathway Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. AMPK Signaling Pathway Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. ErbB/HER Signaling Pathway Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Other Signaling Pathway Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL CELL SIGNALING MARKET: BY REGION 2022-2034 (USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Type
- 8.2.2 By Product
- 8.2.3 By Technology
- 8.2.4 By Pathway
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Type
- 8.3.2 By Product
- 8.3.3 By Technology
- 8.3.4 By Pathway
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Type
- 8.4.2 By Product
- 8.4.3 By Technology
- 8.4.4 By Pathway
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Type
- 8.5.2 By Product
- 8.5.3 By Technology
- 8.5.4 By Pathway
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Type
- 8.6.2 By Product
- 8.6.3 By Technology
- 8.6.4 By Pathway
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL CELL SIGNALING INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific Inc
- 10.2.2 QIAGEN N.V
- 10.2.3 Becton
- 10.2.4 Dickinson And Company
- 10.2.5 Bio-Rad Laboratories Inc
- 10.2.6 Bio-Techne Corporation
- 10.2.7 Cell Signaling Technology Inc
- 10.2.8 Danaher Corporation
- 10.2.9 Merck KGaA
- 10.2.10 PerkinElmer Inc
- 10.2.11 Promega Corporation
